Volume 32, Number 3—March 2026
Emerging Infection Networks Letter
Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe
Table
Risk factors and barriers reported by respondents to a network query into TB infection screening and management among pregnant migrants, Europe, 2025*
| Risk factor or barrier | No. (%) respondents |
|---|---|
| Risk factors considered when screening offered during pregnancy, n = 37† | |
| Recent TB contact | 34 (91.9) |
| HIV infection | 34 (91.9) |
| Immunosuppression | 31 (83.8) |
| Recent migration, <5 y | 22 (59.4) |
| Homelessness | 12 (32.4) |
| Diabetes | 7 (18.9) |
| Malnutrition | 6 (16.2) |
| Risk factors considered when TB preventive treatment offered during pregnancy, n = 31† | |
| HIV infection | 30 (96.8) |
| Recent TB contact | 27 (87.1) |
| Immunosuppression | 22 (71) |
| Recent migration, <5 y | 11 (35.5) |
| Diabetes | 7 (22.6) |
| Malnutrition | 7 (22.6) |
| Homelessness | 5 (16.1) |
| Perceived barriers to TB infection screening, n = 37† | |
| Chest radiograph issues‡ | 28 (75.7) |
| Patient adherence | 11 (29.7) |
| Financial or healthcare system barriers | 10 (27) |
| Guideline gaps | 8 (21.6) |
| Perceived barriers to TB preventive treatment, n = 42† | |
| Patient-related factors | 33 (78.6) |
| Healthcare provider–related factors | 20 (47.6) |
| Guideline or policy gaps | 16 (38.1) |
| Healthcare system barriers | 12 (28.6) |
*TB, tuberculosis. †Multiple responses were permitted. ‡Includes concerns regarding radiation exposure, which trimester radiographs can safely be administered, and patient acceptance of chest radiography during pregnancy.
1These first authors contributed equally to this article.
Page created: March 04, 2026
Page updated: March 23, 2026
Page reviewed: March 23, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.